Exact Sciences
EXAS
#1953
Rank
A$12.86 B
Marketcap
$69.28
Share price
-3.13%
Change (1 day)
-32.44%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

EPS for Exact Sciences (EXAS)

EPS in 2023 (TTM): -$2.36

According to Exact Sciences's latest financial reports the company's current EPS (TTM) is -$2.52. In 2022 the company made an earnings per share (EPS) of -$5.63 a decrease over its 2021 EPS that were of -$5.50.

EPS history for Exact Sciences from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.36-58.13%
2022-$5.632.31%
2021-$5.50-37.09%
2020-$8.74674.65%
2019-$1.13-50.69%
2018-$2.2944%
2017-$1.59-39.39%
2016-$2.62-2.94%
2015-$2.7037.1%
2014-$1.9779.71%
2013-$1.10-21.59%
2012-$1.4062.96%
2011-$0.8692.86%
2010-$0.45-3.45%
2009-$0.46-19.44%
2008-$0.57-18.18%
2007-$0.70-10.2%
2006-$0.78-10.91%
2005-$0.87-24.66%
2004-$1.16-51.33%
2003-$2.38-7.41%
2002-$2.5811.72%
2001-$2.31

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$4.83 91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.54-121.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.64-74.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$80.92 3,110.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.06-300.57%๐Ÿ‡ซ๐Ÿ‡ท France